Search results
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up...
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) announced new long-term data from the ALITHIOS open-label extension study of...
Experimental Therapies for Multiple Sclerosis (MS)
Verywell Health via Yahoo News· 2 years agoThe goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. This article reviews the latest...
Genmab: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 3 months agoGenmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple...
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales
Investor's Business Daily· 1 year agoTG Therapeutics' new multiple sclerosis drug, Briumvi, experienced a "solid jump" in March sales,...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Novartis Stock Hits Record High On A Trio Of First-Quarter Drivers
Investor's Business Daily· 1 year agoNovartis stock jumped to a record high Tuesday after a trio of drugs — including blockbuster heart...
Novartis (NVS) to Divest Xiidra, SAF312 to Streamline Focus
Zacks via Yahoo Finance· 10 months agoNovartis NVS, a leading pharmaceutical company, recently made a strategic decision to divest its...
Can People With MS Get the COVID-19 Vaccine?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Geetika Gupta, MD In some people with multiple sclerosis (MS), certain vaccines can trigger symptom flare-ups. This leads some...
Novartis sees brighter sales future as R&D revamp continues
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: Novartis expects sales to grow faster than anticipated over the next five years as...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 6 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
